Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Therapy Name | PTT-936 |
| Synonyms | |
| Therapy Description |
PTT-936 is an ADP-heptose analog that activates ALPK1, which may enhance antitumor immune response and inhibit tumor growth (Cancer Res (2024) 84 (6_Supplement): 2461). |
| Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
|---|---|---|---|---|
| PTT-936 | PTT 936|PTT936 | PTT-936 is an ADP-heptose analog that activates ALPK1, which may enhance antitumor immune response and inhibit tumor growth (Cancer Res (2024) 84 (6_Supplement): 2461). |
| Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
|---|
| Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
|---|---|---|---|---|---|---|
| NCT06244992 | Phase Ib/II | PTT-936 + unspecified PD-L1 antibody PTT-936 + unspecified PD-1 antibody PTT-936 | PTT-936 Alone or in Combination in Patients With Locally Advanced or Metastatic Solid Tumors | Recruiting | USA | 0 |